David Richard Spinner
We have observed 56 EP applications David Richard Spinner has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 25, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:
METHODS OF TREATING SQUAMOUS CELL CARCINOMA RELATED APPLICATIONS
- IPC classification:
- G01N 33/574
- Applicant:
- Novartis AG
- Agent:
- David Richard Spinner, Novartis Pharma AG
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA
- IPC classification:
- C12Q 1/48
- Agent:
- Philippe Ahner, Brevalex
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
METHOD OF TREATING VISION DISORDERS
- IPC classification:
- A61P 27/02, C07K 16/22
- Applicant:
- Novartis AG
- Agent:
- Multiple attorneys, Novartis Pharma AG
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
DEVICE FOR MANUFACTURING POLYMER FIBERS AND USES THEREOF
- IPC classification:
- A61L 33/06, B29C 47/00, D01D 5/30, D01D 5/38
- Applicant:
- Agency for Science, Technology and Research
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ GRANT OF PATENT INTENDED
METHOD OF TREATING AN OCULAR DISEASE AND COMPOSITIONS EFFECTIVE FOR TREATING AN OCULAR DISEASE
- IPC classification:
- A61K 38/13
- Applicant:
- Howard University
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION IN PROGRESS
SELECTIVE BINDING OF BIOLOGICAL TARGETS TO SOLID PHASE UREIDES
- IPC classification:
- B01D 15/00, C12N 7/02, G01N 33/48
- Applicant:
- Agency for Science, Technology and Research
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ The patent has been granted
MIXED MULTIFUNCTIONAL METAL AFFINITY SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS FIELD
- IPC classification:
- B01D 15/36, B01D 15/38, B01D 39/00, C07C 55/02, C07C 55/22, C07C 211/14, C07C 233/47, C07C 259/06, C07K 1/18
- Applicant:
- Agency for Science, Technology and Research
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ GRANT OF PATENT INTENDED
RECONSTITUTION DEVICE
- IPC classification:
- A61M 5/28, A61M 5/315
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
INDUCTION OF ESTROGEN RECEPTOR BETA BY CHOLESTEROL BIOSYNTHESIS INHIBITORS AND METHODS OF TREATMENT OF CANCER
- IPC classification:
- A61K 31/56, A61K 31/5685, A61P 35/00
- Applicant:
- University Of Missouri
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION IN PROGRESS
ANTIBODIES TO TAU
- IPC classification:
- C07K 16/18, G01N 33/53
- Applicant:
- Washington University
- Agent:
- J A Kemp
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ GRANT OF PATENT INTENDED
SALMONID ALPHAVIRUS AND USES THEREOF
- IPC classification:
- A61K 39/12, C07K 14/18, G01N 33/569
- Applicant:
- Novartis Tiergesundheit AG
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Agent:
- Sean Matthew Alexander, Eli Lilly and Company Limited
- Status:
- █ PATENT GRANTED
GROUPING FOR CLASSIFYING GASTRIC CANCER
- IPC classification:
- C12Q 1/68, G01N 33/574
- Applicant:
- National University of Singapore
- Applicant:
- Agency for Science, Technology and Research
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ GRANT OF PATENT INTENDED
FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE
- IPC classification:
- C07K 14/005, C12Q 1/68
- Applicant:
- Cornell University
- Applicant:
- Center for Technology Licensing (CTL) at Cornell University
- Applicant:
- Novartis Tiergesundheit AG
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Agent:
- Sean Matthew Alexander, Eli Lilly and Company Limited
- Status:
- █ The patent has been granted
CRISPR-BASED GENOME MODIFICATION AND REGULATION
- IPC classification:
- A61K 45/00
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ GRANT OF PATENT INTENDED
CELL LINE AND METHODS FOR IMPROVED GLYCOPROTEIN SIALYLATION
- IPC classification:
- C12N 9/24, C12N 15/113, C12P 21/04, C12P 21/06
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION IN PROGRESS
A POLYMERIC SYSTEM FOR RELEASE OF AN ACTIVE AGENT
- IPC classification:
- A61K 47/30, A61K 47/48, A61L 27/44, A61L 27/50
- Applicant:
- Agency for Science, Technology and Research
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
INTERACTIONS OF BETANODAVIRUSES IN INFECTION
- IPC classification:
- A61K 39/12
- Applicant:
- University of Málaga (Universidad de Malaga)
- Applicant:
- Novartis Tiergesundheit AG
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Agent:
- Sean Matthew Alexander, Eli Lilly and Company Limited
- Status:
- █ GRANT OF PATENT INTENDED
METHODS FOR PREPARING INACTIVATED ROTAVIRUS
- IPC classification:
- A61K 39/12, C12N 7/00
- Applicant:
- Novartis Tiergesundheit AG
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Agent:
- Sean Matthew Alexander, Eli Lilly and Company Limited
- Status:
- █ EXAMINATION IN PROGRESS
PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND A METHOD FOR MAKING THE SAME
- IPC classification:
- C12N 15/82
- Applicant:
- BASF Plant Science Company GmbH
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ APPLICATION PUBLISHED
Compositions and methods for use for antibodies against sclerostin
- IPC classification:
- A61K 31/663, A61K 39/00, A61K 39/395, A61K 45/06, C07K 16/18, C12N 15/13, C12N 15/63, G01N 33/68
- Applicant:
- Novartis AG
- Agent:
- Cameron Marshall, Carpmaels & Ransford LLP
- Agent:
- Multiple attorneys, Novartis Pharma AG
- Status:
- █ PATENT GRANTED
SYNTHETIC POLYMERIC MATERIALS AND DEVICES THEREOF
- IPC classification:
- C08G 63/91, C08G 77/20, C08L 43/04
- Applicant:
- Colorado State University Research Foundation
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ GRANT OF PATENT INTENDED
SEMI-AUTOMATIC SPHYGMOMANOMETER SYSTEM
- IPC classification:
- A61B 5/0225
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ GRANT OF PATENT INTENDED
IMMUNOASSAYS USING OVER-LABELED FLUORESCENT PROBES
- IPC classification:
- G01N 33/53
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ GRANT OF PATENT INTENDED
INTRA-AMNIOTIC ADMINISTRATION OF PROTEINS FOR THE TREATMENT OF ECTODERMAL DYSPLASIAS
- IPC classification:
- A61K 38/00, A61K 39/00
- Applicant:
- University of Erlangen-Nürnberg (Friedrich-Alexander-Universität Erlangen-Nürnberg)
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
METHOD FOR TREATMENT OF DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE
- IPC classification:
- A61K 38/19, A61K 38/21, A61P 25/00, A61P 25/28, A61P 37/00, C07K 14/535
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
METHODS OF DETERMINING AMYLOID BETA TURNOVER IN BLOOD
- IPC classification:
- A61B 5/00, G01N 33/48, G01N 33/68
- Applicant:
- Washington University
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ The patent has been granted
MICRO RNA ISOLATION FROM BIOLOGICAL FLUID
- IPC classification:
- C07H 21/04, C12Q 1/68, G01N 33/53, G01N 33/566
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
BIOMARKERS AND METHODS RELATING TO ALZHEIMER'S DISEASE
- IPC classification:
- G01N 33/68
- Applicant:
- King's College London
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF AMINO ACIDS IN HYDROGENOTROPHIC MICROORGANISMS
- IPC classification:
- C12R 1/01
- Agent:
- Anna Louise Gregson, Mathys & Squire LLP
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
OLIGONUCLEOTIDES FOR MAKING A CHANGE IN THE SEQUENCE OF A TARGET RNA MOLECULE PRESENT IN A LIVING CELL
- IPC classification:
- A61K 31/7088, A61K 48/00, C12N 15/11
- Agent:
- Carpmaels & Ransford LLP
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
ACETAMINOPHEN PROTEIN ADDUCTS AND METHODS OF USE THEREOF
- IPC classification:
- A61K 31/167
- Applicant:
- University of Arkansas
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
INTEGRATED CELLULOSIC ETHANOL PRODUCTION PROCESS
- IPC classification:
- C12N 1/16, C12P 7/06, C12P 7/10, A23L 29/30, A23L 29/212, A23L 7/104
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
CRISPR-BASED GENOME MODIFICATION AND REGULATION
- IPC classification:
- C12N 9/22, C12N 15/10, C12N 15/63
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ APPLICATION PUBLISHED
CRISPR-BASED GENOME MODIFICATION AND REGULATION
- IPC classification:
- C12N 9/22, C12N 15/10, C12N 15/63
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION IN PROGRESS
EPIGENETIC MODIFICATION OF MAMMALIAN GENOMES USING TARGETED ENDONUCLEASES
- IPC classification:
- C12Q 1/02, C12Q 1/68
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
CRISPR-BASED GENOME MODIFICATION AND REGULATION
- IPC classification:
- C12N 9/22, C12N 15/10, C12N 15/63
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
CRISPR-BASED GENOME MODIFICATION AND REGULATION
- IPC classification:
- C12N 9/22, C12N 15/10, C12N 15/63
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ APPLICATION PUBLISHED
PROCESS FOR THE PREPARATION OF A C5-ENRICHED JUICE STREAM
- IPC classification:
- C08B 30/00
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
CRISPR-BASED GENOME MODIFICATION AND REGULATION
- IPC classification:
- C12N 9/22, C12N 15/10, C12N 15/63
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ The patent has been granted
CRISPR-BASED GENOME MODIFICATION AND REGULATION
- IPC classification:
- C12N 9/22, C12N 15/10, C12N 15/63
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ APPLICATION PUBLISHED
TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES
- IPC classification:
- A61K 38/21, A61P 35/00, C07K 16/32, C12N 15/62
- Applicant:
- University of California
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
BOTTOM LOADED PEDICLE SCREW
- IPC classification:
- A61B 17/70
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ EXAMINATION REQUESTED
ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS
- IPC classification:
- A01N 43/50, A01P 1/00, A61K 31/4178, A61P 31/00, C07D 233/56
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
BIOMARKERS OF OSTEOARTHRITIS
- IPC classification:
- C12Q 1/68, G01N 33/53
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ The application has been published
TAU KINETIC MEASUREMENTS
- IPC classification:
- A61K 51/02, A61K 51/08, G01N 33/58, G01N 33/68
- Applicant:
- Washington University
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
GLYCAN ANALYSIS AND PROFILING
- IPC classification:
- C40B 40/12
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
OLIGONUCLEOTIDES FOR GENOMIC DNA EDITING
- IPC classification:
- A61K 31/7088, C12N 15/11
- Agent:
- Carpmaels & Ransford LLP
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE
- IPC classification:
- A61K 39/00, A61K 39/395, C07K 16/00
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
TARGETED RNA EDITING
- IPC classification:
- C12N 15/113
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
VISUALIZING MODIFIED NUCLEOTIDES AND NUCLEIC ACID INTERACTIONS IN SINGLE CELLS
- IPC classification:
- C12N 15/09, C12Q 1/68, G01N 33/50
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
NANOCAPSULES CARRYING CHIKUNGUNYA-ASSOCIATED PEPTIDES
- IPC classification:
- A61K 9/51, A61K 39/12, C07K 14/18, C07K 19/00
- Applicant:
- Nanyang Technological University
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
HIGH SENSITIVITY METHOD FOR EARLY LYME DISEASE DETECTION
- IPC classification:
- G01N 27/62, G01N 30/72, G01N 33/569
- Applicant:
- Colorado State University Research Foundation
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
METHODS AND COMPOSITIONS FOR EXPANSION AND DIFFERENTIATION OF SKELETAL MUSCLE STEM CELLS OR PROGENITOR CELLS
- IPC classification:
- C12N 5/077
- Applicant:
- Agency for Science, Technology and Research
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
OLIGONUCLEOTIDE THERAPY FOR LEBER CONGENITAL AMAUROSIS
- IPC classification:
- A61K 31/712, A61K 31/7125, C12N 15/113
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
OLIGONUCLEOTIDES MATCHING COL7A1 EXON 73 FOR EPIDERMOLYSIS BULLOSA THERAPY
- IPC classification:
- A61K 31/712, A61K 31/7125, C12N 15/113
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made
USING PROGRAMMABLE DNA BINDING PROTEINS TO ENHANCE TARGETED GENOME MODIFICATION
- IPC classification:
- C12N 9/22, C12N 15/10
- Agent:
- David Richard Spinner, Greaves Brewster LLP
- Status:
- █ Request for examination was made